All courses are team-taught by both instructors and many guest speakers.

Martha A. Feldman, R.A.C.
President and CEO, Drug & Device Development Co.; Affiliated Associate Professor, Bioengineering; Instructor, UW Extension Certificate Program in Biomedical Regulatory Affairs

Feldman leads Drug & Device Development Co., where she and her team assist companies in bringing drugs, biologics, biotechnology products and medical devices through the development process to market. Her expertise is in developing and implementing regulatory and clinical strategies, and in troubleshooting regulatory impediments and clinical trial activities. An instructor in the University of Washington Certificate Program in Biomedical Regulatory Affairs, the Certificate Program in Clinical Trials, and the Medical Engineering Program, Feldman is the founding past president of the Organization of Regulatory and Clinical Associates, a major professional organization in the Puget Sound region. She holds an Affiliate Faculty appointment in the UW Department of Bioengineering.

Tom Hazlet, Pharm.D., Dr.P.H.
Associate Professor, Pharmacy, University of Washington (primary instructor)

Dr. Hazlet completed a doctorate in Pharmacy at the University of California, San Francisco and a residency in hospital pharmacy at Yale-New Haven Hospital. He earned a doctorate in Health at the University of California, Berkeley. His prior professional experiences include industrial microbiology, parenteral nutrition research, and pharmacy practice in a community hospital. Most recently, Dr. Hazlet has been a Food and Drug Scientist with the California Department of Health Services' Food and Drug Branch and a member of the Food and Drug Administration's Pacific Region Biotechnology Team. His regulatory activities included reviewing investigational new drug applications and acting as technical liaison with field investigator staff, clinical sponsors, industry representatives, and legislators. His research interests include drug regulation, pharmaceutical policy, bioethics, and technology assessment (including drug formularies).

Instructors are subject to change.